These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 23264610

  • 1. Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.
    Abtahi J, Agholme F, Sandberg O, Aspenberg P.
    J Dent Res; 2013 Mar; 92(3):279-83. PubMed ID: 23264610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [Abstract] [Full Text] [Related]

  • 8. Implant-delivered Alendronate Causes a Dose-dependent Response on Net Bone Formation Around Porous Titanium Implants in Canines.
    Pura JA, Bobyn JD, Tanzer M.
    Clin Orthop Relat Res; 2016 May; 474(5):1224-33. PubMed ID: 26831478
    [Abstract] [Full Text] [Related]

  • 9. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits.
    Chacon GE, Stine EA, Larsen PE, Beck FM, McGlumphy EA.
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1005-9. PubMed ID: 16781331
    [Abstract] [Full Text] [Related]

  • 10. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A, Blanco R.
    Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 13. Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    Rugani P, Kirnbauer B, Acham S, Truschnegg A, Jakse N.
    J Oral Implantol; 2015 Jul; 41 Spec No():377-81. PubMed ID: 24593250
    [No Abstract] [Full Text] [Related]

  • 14. Alendronate/dexamethasone combination therapy worsens soft and hard tissue wound healing around implants in rat maxillae.
    Inoue M, Matsumoto C, Nakajima K, Kuroshima S, Sawase T.
    Bone; 2021 Jul; 148():115942. PubMed ID: 33836307
    [Abstract] [Full Text] [Related]

  • 15. Effect of ovariectomy and alendronate on implant osseointegration in rat maxillary bone.
    Viera-Negrón YE, Ruan WH, Winger JN, Hou X, Sharawy MM, Borke JL.
    J Oral Implantol; 2008 Jul; 34(2):76-82. PubMed ID: 18478902
    [Abstract] [Full Text] [Related]

  • 16. Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.
    Allen MR, Chu TM, Ruggiero SL.
    J Oral Maxillofac Surg; 2013 Jun; 71(6):1017-26. PubMed ID: 23375897
    [Abstract] [Full Text] [Related]

  • 17. Dental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis.
    Mattheos N, Caldwell P, Petcu EB, Ivanovski S, Reher P.
    J Can Dent Assoc; 2013 Jun; 79():d2. PubMed ID: 23763726
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate coating might improve fixation of dental implants in the maxilla: a pilot study.
    Abtahi J, Tengvall P, Aspenberg P.
    Int J Oral Maxillofac Surg; 2010 Jul; 39(7):673-7. PubMed ID: 20452185
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 20. Osteopathology induced by bisphosphonates and dental implants: clinical observations.
    Jacobsen C, Metzler P, Rössle M, Obwegeser J, Zemann W, Grätz KW.
    Clin Oral Investig; 2013 Jan; 17(1):167-75. PubMed ID: 22415216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.